If you liked this article you might like

Hologic Looks Good on the Charts
Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls
Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers
Cramer: These Sectors Look Bullish (Part III)